EP1190089A4 - Methods of treatment using lig 72a and variants thereof - Google Patents

Methods of treatment using lig 72a and variants thereof

Info

Publication number
EP1190089A4
EP1190089A4 EP00946845A EP00946845A EP1190089A4 EP 1190089 A4 EP1190089 A4 EP 1190089A4 EP 00946845 A EP00946845 A EP 00946845A EP 00946845 A EP00946845 A EP 00946845A EP 1190089 A4 EP1190089 A4 EP 1190089A4
Authority
EP
European Patent Office
Prior art keywords
lig
variants
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00946845A
Other languages
German (de)
French (fr)
Other versions
EP1190089A2 (en
Inventor
Sharon Bingham
John Darker
Wu-Schyong Liu
John D Martin
Andrew A Parsons
Saraswati R Patel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Ltd
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd, SmithKline Beecham Corp filed Critical SmithKline Beecham Ltd
Publication of EP1190089A2 publication Critical patent/EP1190089A2/en
Publication of EP1190089A4 publication Critical patent/EP1190089A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP00946845A 1999-06-25 2000-06-22 Methods of treatment using lig 72a and variants thereof Withdrawn EP1190089A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14115699P 1999-06-25 1999-06-25
US141156P 1999-06-25
PCT/US2000/017251 WO2001000787A2 (en) 1999-06-25 2000-06-22 Methods of treatment using lig 72a and variants thereof

Publications (2)

Publication Number Publication Date
EP1190089A2 EP1190089A2 (en) 2002-03-27
EP1190089A4 true EP1190089A4 (en) 2002-10-16

Family

ID=22494432

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00946845A Withdrawn EP1190089A4 (en) 1999-06-25 2000-06-22 Methods of treatment using lig 72a and variants thereof

Country Status (2)

Country Link
EP (1) EP1190089A4 (en)
WO (1) WO2001000787A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030022277A1 (en) * 1995-05-05 2003-01-30 Daniel R. Soppet Human neuropeptide receptor
WO2004071395A2 (en) * 2003-02-17 2004-08-26 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g protein-coupled receptor ox1r (ox1r)
JP6697403B2 (en) 2014-06-24 2020-05-20 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル Methods and pharmaceutical compositions for the treatment of inflammatory bowel disease
EP3454857A1 (en) 2016-05-10 2019-03-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of autoimmune inflammatory diseases
WO2019209800A1 (en) * 2018-04-23 2019-10-31 The Trustees Of Columbia University In The City Of New York Fluid responsive devices and methods

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999030670A2 (en) * 1997-12-15 1999-06-24 Smithkline Beecham Plc Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309854B1 (en) * 1996-12-17 2001-10-30 Smithkline Beecham Corporation Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999030670A2 (en) * 1997-12-15 1999-06-24 Smithkline Beecham Plc Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DARKER J G ET AL: "Structure-activity analysis of truncated orexin-A analogues at the orexin-1 receptor", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, vol. 11, no. 5, 12 March 2001 (2001-03-12), pages 737 - 740, XP004230101, ISSN: 0960-894X *
See also references of WO0100787A3 *

Also Published As

Publication number Publication date
EP1190089A2 (en) 2002-03-27
WO2001000787A3 (en) 2002-01-24
WO2001000787A2 (en) 2001-01-04

Similar Documents

Publication Publication Date Title
HK1161893A1 (en) Treatment of coal
GB2351661B (en) Novel method of treatment
HUP0200344A3 (en) Use of gabapentin derivative for preventing and treating visceral pain
IL145875A0 (en) Novel method of treatment
KR100510795B1 (en) Compositions and Methods for the Treatment of Tumor
EP1183030A4 (en) Methods of making and using n-desmethylzopiclone
EP1176940A4 (en) Fingernail hardening treatment
GB9911772D0 (en) Diagnosis and treatment of atherosclerosis
EP1190089A4 (en) Methods of treatment using lig 72a and variants thereof
GB2360453B (en) Treatment of skin conditions
EP1173189A4 (en) Asialocytokines and treatment of liver disease
IL149281A0 (en) Treatment of cancer
GB9930688D0 (en) Novel method of treatment
EP1303281A4 (en) Methods of treatment
IL150208A0 (en) Compound and method for the treatment of pain
KR100511819B1 (en) Compositions and Methods for the Treatment of Tumor
GB9917181D0 (en) Methods of treatment
GB9901310D0 (en) Methods of treatment
KR100526723B1 (en) Compositions and Methods for the Treatment of Tumor
KR100512820B1 (en) Compositions and Methods for the Treatment of Tumor
GB9930696D0 (en) Novel method of treatment
GB9926359D0 (en) Treatment of alopecia
GB0115943D0 (en) Treatment and diagosis of cancer
EP1165060A4 (en) Treatment of gallstones
GB9824791D0 (en) Novel methods of treatment

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011214

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SMITHKLINE BEECHAM PLC

Owner name: SMITHKLINE BEECHAM CORPORATION

A4 Supplementary search report drawn up and despatched

Effective date: 20020829

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20070205

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070817